SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.
- DOI
- 10.2337/dc26-0999
- Published
- 2026 Sep 3
- Container
- Diabetes care
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2337/dc26-0999,
title = {SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.},
author = {Rosen J and de Boer IH and Eckel RH and McGuire DK and Peters AL and Pop-Busui R and Tuttle KR and Vaduganathan M and Dutta S},
year = {2026},
journal = {Diabetes care},
doi = {10.2337/dc26-0999},
url = {https://doi.org/10.2337/dc26-0999}
}RIS
TY - JOUR TI - SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes. AU - Rosen J AU - de Boer IH AU - Eckel RH AU - McGuire DK AU - Peters AL AU - Pop-Busui R AU - Tuttle KR AU - Vaduganathan M AU - Dutta S PY - 2026 JO - Diabetes care DO - 10.2337/dc26-0999 UR - https://doi.org/10.2337/dc26-0999 ER -
APA
J, R., IH, D. B., RH, E., DK, M., AL, P., R, P., KR, T., M, V., & S, D. (2026). SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.. Diabetes care. https://doi.org/10.2337/dc26-0999
Source records
- pubmed · retrieved 2026-09-26T00:47:47.829Z